Chondroplasty Market Anticipated To Witness Robust Growth, Surpassing $18.43 Billion By 2029

The Chondroplasty Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Chondroplasty Market Size and Its Estimated Growth Rate?
The market size for chondroplasty has seen significant growth in recent years. It will escalate from $13.77 billion in 2024 to $14.68 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. The augmentation in the historic period could be accredited to the rise in sports-related injuries, patients' inclination towards non-total joint replacement, advancements in postoperative care, enhancements in healthcare provider training and skills, and a growing number of joint disorders.

The market for chondroplasty is anticipated to expand steadily in the upcoming years, reaching a value of $18.43 billion by 2029, with a compound annual growth rate (CAGR) of 5.9%. The projected expansion during the forecast period is due to factors such as the fusion of regenerative medicine, an emphasis on outpatient procedures, the introduction of innovative biomaterials, increased instances of musculoskeletal disorders, and an increasing elderly population. Key trends anticipated during this period include the integration of technology in rehabilitation, the use of arthroscopic techniques, advancements in cartilage repair and regeneration, innovative developments in surgical instruments, and the incorporation of navigation systems.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13185

How Are Emerging Segments Shaping the Chondroplasty Market Landscape?
The chondroplasty market covered in this report is segmented -

1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types
2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies
3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments
4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses

Subsegments:
1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation, Low-Frequency Ablation
2) By Abrasion Chondroplasty: Mechanical Abrasion, Arthroscopic Abrasion
3) By Patellar Chondroplasty: Open Patellar Chondroplasty, Arthroscopic Patellar Chondroplasty
4) By Meniscal Repair: Suturing Techniques, Meniscal Allograft Transplantation
5) By Tissue Removal: Arthroscopic Debridement, Open Debridement
6) By Other Types: Microfracture Techniques, Osteochondral Autograft Transplantation

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

Which Growth Factors Are Influencing Chondroplasty Market Expansion?
The escalating number of joint-related disorders is anticipated to stimulate the growth of the chondroplasty market. These disorders can impair the health and proper functioning of a joint, often resulting from overexertion of a joint or sudden injuries, such as accidents or athletic injuries. Chondroplasty is a treatment method for these disorders, which fixes the damaged cartilage within a joint. For instance, The Lancet, a UK-based publication house, reported in August 2023 that the diagnosis of gout, an inflammatory joint disease, rose from 1.40 cases per 1,000 adults in March 2021 to 1.44 cases per 1,000 adults in March 2022 in the UK. Hence, the escalating number of joint-related disorders is steering forward the progress of the chondroplasty market. The upward trend in knee surgeries is likely to boost the expansion of the chondroplasty market. Knee surgery, which address various knee-related conditions or injuries, is a key driver. Chondroplasty, which is primarily used to mend and reshape damaged knee joint cartilage, has gained prominence in these surgeries. For instance, the National Library of Medicine, a US-based government library, revealed in February 2022 that over 2.4 million hip and knee procedures were performed in over 1150 facilities, marking an 18.3% rise from 2020 totals. Furthermore, the same source reported in January 2023 that the volume of total knee arthroplasty (TKA) is predicted to surge by 139% by 2040 and 469% by 2060. Hence, the growing trend in knee surgeries is fuelling the growth of the chondroplasty market.

Who Are the Dominant Players Across Different Chondroplasty Market Segments?
Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

What Chondroplasty Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the chondroplasty market are pioneering the creation of autologous chondrocytes to improve cartilage repair, leveraging the patient's own cells to minimize immune rejection and facilitate organic regeneration. Autologous chondrocytes, sourced from a patient's body - usually a non-weight-bearing joint area, are a revolutionary development. Vericel Corporation, an American biopharmaceutical company, for example, got FDA approval and began the commercial roll-out of MACI Arthro (Matrix Autologous Chondrocyte Implantation) in August 2024. This significant advancement in treating knee cartilage defects enables orthopedic surgeons to conduct the operation via small incisions using innovative instruments, making it considerably less invasive than traditional techniques. Such an approach is predicted to accelerate patient recovery and decrease complications post-surgery.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report

Which Geographic Regions Are Expected to Dominate the Chondroplasty Market in the Coming Years?
North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chondroplasty Market?
2. What is the CAGR expected in the Chondroplasty Market?
3. What Are the Key Innovations Transforming the Chondroplasty Industry?
4. Which Region Is Leading the Chondroplasty Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.